mtx-463
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 15, 2024 (NCT06401213)
Timeline
Indications
Mechanism of action
- CCN family member 4INHIBITOR
CCN4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06967805 | Phase 2 | May 5, 2025 | Medeor Therapeutics, Inc. |
| NCT06401213 | Phase 1 | Apr 15, 2024 | ICON, Medeor Therapeutics, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medeor Therapeutics, Inc. | For profit | 2 | 2 | 2 | 2024 |
| ICON | For profit | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1